NCT07074691 is a NA clinical trial of Regional Dexamethasone in Regional, sponsored by Tanta University.

Who is sponsoring NCT07074691?

NCT07074691 is sponsored by Tanta University.

What drugs are being tested in NCT07074691?

Interventions in NCT07074691: Regional Dexamethasone, Intravenous Dexamethasone.

What condition does NCT07074691 study?

NCT07074691 studies Regional, Intravenous, Dexamethasone, Prophylaxis, Rebound Pain, Supraclavicular Block, Upper Limb Surgeries.

Is NCT07074691 still recruiting?

NCT07074691 is currently completed. Last updated 20 July 2025.

Last reviewed 2025-07-20 · How we verify

NCT07074691

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Regional and Intravenous Dexamethasone in The Prophylaxis of Rebound Pain After Supraclavicular Block in Upper Limb Surgeries

Completed NA Last updated 20 July 2025

What this trial tests

NA trial testing Regional Dexamethasone in Regional in 90 participants. Completed in 1 February 2025.

Timeline

1 March 2023

Primary endpoint
1 February 2025

1 February 2025

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	1 March 2023
Primary completion	1 February 2025
Estimated completion	1 February 2025
Sites	1 location across Egypt

Drugs / interventions tested

Regional Dexamethasone — full drug profile →
Intravenous Dexamethasone — full drug profile →

Conditions studied

Regional — all drugs for Regional →
Intravenous — all drugs for Intravenous →
Dexamethasone — all drugs for Dexamethasone →
Prophylaxis — all drugs for Prophylaxis →

Sponsor

Tanta University

Who can join

Adults 21 to 65, any sex, with Regional or Intravenous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare the effect of regional and intravenous Dexamethasone in the prophylaxis of rebound pain after supraclavicular block in upper limb surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07074691 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 20 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07074691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing